Skip to main content
EyePoint Pharmaceuticals, Inc. logo

EyePoint Pharmaceuticals, Inc. — Investor Relations & Filings

Ticker · EYPT ISIN · US74440J1016 LEI · 549300QE1RU34T50MR69 US Manufacturing
Open in API
Filings indexed 1,019 across all filing types
Latest filing 2016-10-06 Proxy Solicitation & In…
Country US United States of America
Listing US EYPT

About EyePoint Pharmaceuticals, Inc.

https://eyepointpharma.com/

EyePoint Pharmaceuticals is a clinical-stage biopharmaceutical company focused on developing and commercializing therapeutics for serious retinal diseases. The company leverages its proprietary Durasert E™ technology, a bio-erodible platform for sustained intraocular drug delivery, to create durable therapies. Its lead investigational product, DURAVYU™ (EYP-1901), combines the tyrosine kinase inhibitor vorolanib with the Durasert E™ system for the potential treatment of VEGF-mediated retinal diseases. The company's goal is to improve patient outcomes and reduce treatment burden by providing long-lasting treatments for chronic eye conditions.

Recent filings

Filing Released Lang Actions
PRE 14A
Proxy Solicitation & Information Statement Classification · 100% confidence The document is a Schedule 14A proxy statement filed with the SEC, as indicated by the header 'SCHEDULE 14A' and references to 'Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934'. It includes detailed information about the upcoming Annual Meeting of Stockholders, including date, time, location, agenda items such as election of directors, approval of executive compensation, and ratification of auditors. It also contains voting instructions and detailed biographies of board members. The document is not an annual report, earnings release, or any other financial report but is clearly a proxy solicitation document intended to provide shareholders with information to vote on corporate matters at the annual meeting. Therefore, the correct classification is Proxy Solicitation & Information Statement (PSI). The document length (15,000 characters) and content confirm it is the full proxy statement, not just an announcement or notice.
2016-10-06 English
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K current report filed with the SEC, dated September 26, 2016. The key content is the appointment of a new director, Jay S. Duker, to the board and related details about his background and compensation. The document explicitly states this is an announcement of a board change (Item 5.02). There is no financial data or report content, only a disclosure of management/board changes. Therefore, this fits the category of Board/Management Information (MANG). The document length is under 5,000 characters and is a direct announcement, not a report or certification, so it is not RPA or RNS. Hence, the classification is MANG with high confidence.
2016-09-28 English
PRIMARY DOCUMENT
Director's Dealing
2016-09-27 English
FORM 8-K
Board/Management Information Classification · 100% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce major events that shareholders should know about. The content specifically details the appointment of a new President and CEO, Nancy S. Lurker, and the departure of the previous CEO. It includes biographical information, terms of employment, severance details, and related corporate governance changes. This matches the description of Board/Management Information filings, which announce changes in the company's board of directors or senior management. The document is not a full annual or quarterly report, nor is it an earnings release or proxy statement. It is not a regulatory filing of miscellaneous nature but a specific announcement about management changes. Therefore, the correct classification is MANG (Board/Management Information). The document length and detail support a high confidence in this classification.
2016-09-20 English
PRIMARY DOCUMENT
Director's Dealing
2016-09-20 English
FORM 10-K
Annual Report FY 2016
2016-09-13 English

Browse filings by year

19 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.